vs
太平洋生物科学（ASMB）与VALUE LINE INC（VALU）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是VALUE LINE INC的1.3倍（$10.8M vs $8.3M），VALUE LINE INC净利率更高（71.4% vs -85.2%，领先156.6%），太平洋生物科学同比增速更快（57.6% vs -7.7%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
价值线公司是一家总部位于纽约的上市投资研究与金融出版企业，由阿诺德·伯恩哈德于1931年创立。该公司最为人熟知的业务是出版《价值线投资调查》，这份股票分析刊物跟踪覆盖约1700只上市个股的行情与研究。
ASMB vs VALU — 直观对比
营收规模更大
ASMB
是对方的1.3倍
$8.3M
营收增速更快
ASMB
高出65.3%
-7.7%
净利率更高
VALU
高出156.6%
-85.2%
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $8.3M |
| 净利润 | $-9.2M | $5.9M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | 12.1% |
| 净利率 | -85.2% | 71.4% |
| 营收同比 | 57.6% | -7.7% |
| 净利润同比 | 4.3% | 14.5% |
| 每股收益（稀释后） | $-0.72 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBVALU
| Q1 26 | — | $8.3M | ||
| Q4 25 | — | $8.6M | ||
| Q3 25 | $10.8M | $8.6M | ||
| Q2 25 | $9.6M | $8.4M | ||
| Q1 25 | $9.4M | $9.0M | ||
| Q4 24 | $7.4M | $8.8M | ||
| Q3 24 | $6.8M | $8.9M | ||
| Q2 24 | $8.5M | $9.0M |
净利润ASMBVALU
| Q1 26 | — | $5.9M | ||
| Q4 25 | — | $5.7M | ||
| Q3 25 | $-9.2M | $6.5M | ||
| Q2 25 | $-10.2M | $4.0M | ||
| Q1 25 | $-8.8M | $5.2M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | $-9.6M | $5.9M | ||
| Q2 24 | $-11.2M | $4.8M |
营业利润率ASMBVALU
| Q1 26 | — | 12.1% | ||
| Q4 25 | — | 17.7% | ||
| Q3 25 | -100.9% | 17.4% | ||
| Q2 25 | -115.2% | 9.9% | ||
| Q1 25 | -105.5% | 17.4% | ||
| Q4 24 | — | 19.7% | ||
| Q3 24 | -160.1% | 20.8% | ||
| Q2 24 | -143.0% | 16.5% |
净利率ASMBVALU
| Q1 26 | — | 71.4% | ||
| Q4 25 | — | 66.4% | ||
| Q3 25 | -85.2% | 75.1% | ||
| Q2 25 | -105.9% | 47.1% | ||
| Q1 25 | -93.6% | 57.6% | ||
| Q4 24 | — | 64.3% | ||
| Q3 24 | -140.4% | 66.3% | ||
| Q2 24 | -130.7% | 53.1% |
每股收益（稀释后）ASMBVALU
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-0.72 | — | ||
| Q2 25 | $-1.33 | — | ||
| Q1 25 | $-1.17 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.51 | — | ||
| Q2 24 | $-1.98 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $107.8M |
| 总资产 | $240.0M | $151.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBVALU
| Q1 26 | — | $92.5M | ||
| Q4 25 | — | $86.6M | ||
| Q3 25 | $22.5M | $33.7M | ||
| Q2 25 | $24.0M | $67.7M | ||
| Q1 25 | $23.4M | $52.8M | ||
| Q4 24 | $38.3M | $22.3M | ||
| Q3 24 | $28.5M | $30.9M | ||
| Q2 24 | $19.2M | $4.4M |
股东权益ASMBVALU
| Q1 26 | — | $107.8M | ||
| Q4 25 | — | $105.5M | ||
| Q3 25 | $182.7M | $103.0M | ||
| Q2 25 | $18.1M | $99.7M | ||
| Q1 25 | $27.1M | $99.0M | ||
| Q4 24 | $33.4M | $96.7M | ||
| Q3 24 | $26.0M | $93.9M | ||
| Q2 24 | $34.7M | $90.8M |
总资产ASMBVALU
| Q1 26 | — | $151.0M | ||
| Q4 25 | — | $147.9M | ||
| Q3 25 | $240.0M | $148.2M | ||
| Q2 25 | $80.8M | $144.5M | ||
| Q1 25 | $99.0M | $143.6M | ||
| Q4 24 | $119.2M | $140.0M | ||
| Q3 24 | $100.3M | $138.6M | ||
| Q2 24 | $115.3M | $136.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $5.3M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 0.89× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBVALU
| Q1 26 | — | $5.3M | ||
| Q4 25 | — | $3.0M | ||
| Q3 25 | $-15.1M | $5.6M | ||
| Q2 25 | $-16.8M | $20.2M | ||
| Q1 25 | $-23.4M | $6.9M | ||
| Q4 24 | $-51.1M | $3.1M | ||
| Q3 24 | $-15.2M | $4.8M | ||
| Q2 24 | $-17.1M | $17.9M |
自由现金流ASMBVALU
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-15.2M | — | ||
| Q2 25 | — | $20.1M | ||
| Q1 25 | — | $6.8M | ||
| Q4 24 | $-51.1M | $3.0M | ||
| Q3 24 | — | $4.8M | ||
| Q2 24 | $-17.1M | $17.9M |
自由现金流率ASMBVALU
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -140.7% | — | ||
| Q2 25 | — | 239.2% | ||
| Q1 25 | — | 75.3% | ||
| Q4 24 | -695.2% | 34.1% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | -200.6% | 199.0% |
资本支出强度ASMBVALU
| Q1 26 | — | 0.0% | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.0% | 2.1% | ||
| Q1 25 | 0.0% | 1.2% | ||
| Q4 24 | 0.4% | 0.7% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.2% | 0.2% |
现金转化率ASMBVALU
| Q1 26 | — | 0.89× | ||
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 5.12× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | 0.54× | ||
| Q3 24 | — | 0.81× | ||
| Q2 24 | — | 3.75× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
